Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex v... Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. Mehr anzeigen
WOBURN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
WOBURN, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 0.15873015873 | 12.6 | 13.56 | 11.93 | 708884 | 12.34567322 | CS |
| 4 | -0.48 | -3.6641221374 | 13.1 | 13.56 | 11.19 | 748091 | 12.36315665 | CS |
| 12 | 1.56 | 14.1048824593 | 11.06 | 16.52 | 9.94 | 781736 | 12.6885256 | CS |
| 26 | 4.12 | 48.4705882353 | 8.5 | 16.52 | 7.86 | 733952 | 11.58108692 | CS |
| 52 | 3.77 | 42.5988700565 | 8.85 | 16.52 | 4.92 | 1034500 | 9.16961948 | CS |
| 156 | -14.62 | -53.671071953 | 27.24 | 30.89 | 4.92 | 729274 | 13.14447344 | CS |
| 260 | -1.78 | -12.3611111111 | 14.4 | 54.85 | 4.92 | 559921 | 17.72265596 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
